Delivery Order SPE2DB22D3301-SPE2DB24FY3KS
- Not listed
- This federal contract award, valued at $24,590.54, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is a firm fixed price delivery order for the supply of POMALYST 1 MG CAPSULE 21S, a pharmaceutical product. The award has an ultimate completion date of May 3, 2024. Amerisourcebergen Drug Corp is the prime contractor on an...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,287.90, is for the delivery of POMALYST 2 MG CAPSULE 21S, a specialty pharmaceutical product. The contract has an ultimate completion date of April 1, 2024 and is a firm fixed-price arrangement. This award is not designated as a set-aside contract. AmerisourceBergen Drug...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The $12,287.90 firm fixed price delivery order is for the supply of the pharmaceutical product Pomalyst 2 mg capsules. Amerisourcebergen Drug Corporation is the prime contractor on this award, which does not have a set-aside designation. The award is associated with a larger indefinite delivery contract (IDC) valued at up to...
- This federal contract award, valued at $228,295.22, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Pomalyst 1 mg capsules, a specialty medication, to support military healthcare programs. The contract is a Firm Fixed Price Delivery Order with a period of performance through March 2025. It is not designated as a set-aside contract. AmerisourceBergen holds a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Pomalyst 4 mg capsules (21-count units) with a ceiling value of $41,555.25. This firm fixed price delivery order, with an ultimate completion date of September 10, 2025, represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the place of performance and fulfills this order...
- The Defense Logistics Agency awarded a $13,851.75 delivery order to AmerisourceBergen Drug Corp for Pomalyst 4 mg capsules (21-count packages) on September 11, 2025, with an ultimate completion date of October 2, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded to the prime contractor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- This federal contract award is a firm fixed price delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $11,912.37 award is for the provision of pharmaceutical products and medical supplies to support military treatment programs and facilities. Amerisourcebergen Drug Corp serves as the prime contractor on an indefinite delivery contract...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical. The $1,315.44 contract is for the provision of pharmaceutical products and medical supplies to support military treatment programs and facilities. Amerisourcebergen Drug Corp, as the prime contractor, will deliver a comprehensive range of specialty, brand name, generic, and over-the-counter...
- This federal contract award is a firm fixed price delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $3,449.56 award is for the provision of pharmaceutical products and medical supplies to support military treatment programs and facilities. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which has a performance period through February 29, 2024. This...
- This federal contract award is for a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, the prime contractor, to provide pharmaceutical and medical supply products. The award has a firm fixed price of $1,132.80 and a completion date of February 27, 2024. Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation, will deliver the requested products from its Corporate...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB24FY3KSDelivery Order
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $12,295.26 firm fixed price contract is for the supply of POMALYST 1 MG CAPSULE 21S, a specialty pharmaceutical product. The award has an ultimate completion date of April 17, 2024. Amerisourcebergen Drug Corp is a prime contractor that provides a wide range of pharmaceutical products and medical supplies to U.S. government agencies, particularly the Department of Defense. This award is associated with a larger $999,999,999.00 indefinite delivery contract (IDC) that Amerisourcebergen Drug Corp holds with DLA. The IDC serves as the primary vehicle for Amerisourcebergen to deliver pharmaceuticals and medical materials to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designations were used for this contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.3k | 3/27/24 |